Page 128 - Read Online
P. 128

Page 4 of 20                   Akinci et al. Vessel Plus 2021;5:56  https://dx.doi.org/10.20517/2574-1209.2021.20

               In addition to aggravating primary brain injury by causing increased hematoma, elevated BP also influences
               secondary brain injury through affecting brain swelling, inflammation, apoptosis and necrosis. RAS
               inhibition has been reported to reduce inflammation, oxidative stress, and infarct volume, modulate nitric
                                                                                                       [12]
               oxide synthase isoenzymes in animal stroke models, and improve functional outcome in stroke patients .
               Stimulation of brain and cerebrovascular Ang II systems in rats has been shown to increase micro vessel
                                                                                             [26]
               permeability, and expression of proinflammatory factors and contribute to vasoconstriction . Angiotensin
               II type 1 receptors (Ang II AT1) in neurons, astrocytes, microglia, and brain microvascular endothelial cells
               are likely to play a role in inflammatory response modulation in hypertensive state [27-29] . Long-term brain
               Ang II AT1 receptor blockade protects the brain from the pathological effects of stress and from ischemia,
                                                            [30]
               partly through peripheral anti-inflammatory effects . Evidence suggests that elevated systemic BP can
               increase norepinephrine concentration in the subfornix . Norepinephrine acts at beta-adrenoreceptors and
                                                              [31]
               selective beta-adrenoreceptor 1 antagonists have been shown to provide neuroprotective effects in ischemic
               stroke models [32,33] .


               RECONSIDERING THE DEFINITION OF ACUTE HYPERTENSIVE RESPONSE
               In a rat model of collagenase-induced ICH study, an ultra-acute elevation in SBP following induction of
               ICH has been observed in both normotensive rats and rats with renovascular hypertension (RVHT) [mean
               arterial pressure (MAP) in RVHT rats increased from 131.9 ± 12.6 mmHg to 138.9 mmHg; in normotensive
               rats increased from 85.7 ± 11.5 mmHg to 89.5 mmHg at 30 min after ICH] and elevated SBP increased
               hematoma volume, brain edema, and perihematomal apoptosis . However, the hematoma volume was
                                                                      [12]
               60% greater in RVHT rats and correlated with more severe neurological deficits at three weeks.
               Additionally, the increase in heart rate observed during the hyperacute phase in normotensive rats was not
               observed in RVHT rats, probably due to an altered cardiovascular response.


               In another experimental study with rodents, researchers compared the amount of bleeding that chronic
               hypertensive and normotensive rats experienced after brain surgery while the BP values of the subjects are
               kept at the presurgical levels . Comparison of normotensive, acutely hypertensive, spontaneously
                                         [34]
               hypertensive (antihypertensive treatment given and not given) rats showed that only the hematoma volume
               of acutely hypertensive rats was larger. These findings were thought to provide evidence that the brains of
               spontaneously hypertensive rats are presumably protected against excessive bleeding due to increased
               resistance in large cerebral arteries resulting in reduced cerebral intravascular pressure.


               Acute hypertensive response is defined as “SBP ≥ 140 mmHg” consistent with the 2003 World Health
               Organization/International Society of Hypertension statement but, is it appropriate to use this definition in
               both patients with and without chronic hypertension ? Should the diagnosis and treatment criteria for
                                                             [35]
               acute hypertensive response be the same in two patients with ICH of the same size and location, one with
               chronic hypertension and the other without, represented by the same arterial BP value or the same amount
               of increase in pre-morbid BP values? From the animal experiments mentioned above, we can easily deduce
               that the outcome of these two patients will be different even with the same treatment. However, it seems
               quite difficult to classify patients in this way in randomized studies. Since hypertension can be
               asymptomatic for years, it is nearly impossible to predict whether the hypertension detected in an ICH
               patient at the time of presentation without a history of chronic hypertension is the cause, the result or a
               contributing factor, except for a few clues (patients over 45 years of age; the observation of left ventricular
               hypertrophy by electrocardiogram, and cardiomegaly by chest radiography; retinal changes; the observation
               of homogeneous, oval or round smooth-looking hematomas, surrounded by a thin rim of edema that can
               expand for a few days, with periventricular white matter and the protuberance involvement in
               neuroimaging suggest that the ICH is secondary to hypertension-related angiopathy) [16,36] . However,
   123   124   125   126   127   128   129   130   131   132   133